Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
20.6M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
10.4M
-
Shares change
-
+285K
-
Total reported value, excl. options
-
$70.4M
-
Value change
-
+$1.93M
-
Number of buys
-
19
-
Number of sells
-
-4
-
Price
-
$6.77
Significant Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) as of Q1 2025
28 filings reported holding ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share as of Q1 2025.
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.4M shares
of 20.6M outstanding shares and own 50.45% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (9.89M shares), Voss Capital, LP (142K shares), NORTHERN TRUST CORP (53.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (47.6K shares), GEODE CAPITAL MANAGEMENT, LLC (33.5K shares), NORTHWESTERN UNIVERSITY (27.8K shares), Sigma Planning Corp (23.7K shares), GOLDMAN SACHS GROUP INC (22.4K shares), VANGUARD GROUP INC (18.6K shares), and ROYAL BANK OF CANADA (18.5K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.